TMC - AGM Information 2024 | FinancialReports.eu

Taiwan Mask Corporation

Minutes for 2024 Annual General Meeting of Shareholders

Time: 09:00 am, May 27, 2024 (Monday)

Location: No. 188, Section 2, Zhonghua Road, East District, Hsinchu City, 13th Floor, Conference Room, Ambassador Hotel

Attendance: The total number of shares represented by shareholders and proxies in attendance was 132,301,176 (including 19,316,868 shares by electronic means), representing 61.92% of the total number of 213,653,035 issued shares (after deducting 42,793,440 shares without voting rights under Article 179 of the Company Act).

==> picture [52 x 45] intentionally omitted <==

Chairperson: Chairman Sean Chen Minute Taker: Chiao-Jin Tseng

Directors in Presence: Sean Chen, Chairman, Lidon Chen and Chao-Yi Wu, both directors, and Wei-Chen Wang (convener of the Audit Committee), Huan-Kuei Cheng, and Hui-Fen Chan, independent directors, for a total of 6 directors, which exceeds half of the 7 seats of the Board of Directors.

Attendance: Eve Yang, CFO, and Ya-Hui Cheng, CPA

I. Call the meeting to order: The number of shares present has reached the quorum, and the chairperson announced the start of the meeting.
II. Chairperson’s opening remarks: Omitted.
III. Report:
(I) Please refer to Attachment 1 for the 2023 business report.
(II) Please refer to Attachment 2 for the report on the Audit Committee’s review of the Company’s 2023 business and accounting reports.
(III) Report on the Company’s distribution of employees and directors’ profit-sharing remuneration for 2023.
- The 2023 remuneration for employees and directors has been approved by the board resolution at the meeting held on March 6, 2024. According to the Articles of Incorporation, NT$12,000,000, or 1.70% of the profit, is allocated as director remuneration; NT$80,000,000, or 11.36% of the profit, is allocated as employee remuneration, all of which will be paid in cash.
1 -
(IV) Report on the 2023 profit and distribution of cash dividends.
According to the provisions of Article 23-1 of the Articles of Incorporation, if the Company distributes all or part of the dividends and bonuses or legal reserve and capital surplus in the form of cash, the Board of Directors is authorized to do so with the presence of at least two-thirds of the directors and the approval of a majority of the directors present, and to report to the shareholders’ meeting.
The 2023 profit distribution allocates NT$1.5 per share to be distributed in cash as shareholder dividends. Distribution of cash dividends adopts the calculation method of “round down to the nearest dollar,” fractions that do not amount to a full NT$1 shall be added and recognized by the Company as other income.
While the aforementioned distribution of earnings is kept at NT$1.5 per share, if there are regulatory changes by the competent authority or changes to the Company’s capital, such as conversion of convertible bonds into equity, which affect the number of shares outstanding before the dividends record date, the Chairman is authorized to make changes to the profit distribution schedule, dividends record date and payment date and other relevant matters.
(V) Report on the endorsement and guarantee of the Company and its subsidiaries for 2023.
In accordance with the Company’s endorsement and guarantee measures, the Company and its subsidiaries shall submit the endorsement and guarantee conditions during each business year and related matters to the next annual shareholders’ meeting for review.
Please refer to Attachment 3 for the endorsement and guarantee of the Company and its subsidiaries for the year ended December 31, 2023.
(VI) Report on the Company’s domestic secured corporate bonds.
The Company was approved by the board at the meeting held on August 4, 2023 to issue secured corporate bonds no more than NT$1 billion to repay loans from financial institutions or raise working capital.
In 2023, the Company issued domestic secured corporate bonds in NTD twice, with a total amount of NT$800 million. The amount and terms of each issue are as follows:
2 -

Bond period	Date of issue: (year/month/day)	Amount Issued (NT$)	Term (year)	Annual interest rate (Fixed) (%)	Maturity date (year/month/day)	Guaranteeing bank
1st of 2023	08/28/2023	NT$300 million	5 years	1.62%	08/28/2028	Taiwan Cooperative Bank
2nd of 2023	12/12/2023	NT$500 million	5 years	1.80%	12/12/2028	HUA NAN COMMERCIAL BANK , LTD
Interestpayment method		Simple interest calculated and interestpaid once ayear
Principal repayment		A single repayment ofprincipal at maturity

(VII) Report on the status of the issue of common shares by private placement approved by the 2023 annual general meeting.
The annual general meeting on May 24, 2023 resolved to approve the issuance of no more than 75,000 thousand common shares by private placement for capital increase on cash. In accordance with the provisions of Article 43-6 of the Securities and Exchange Act, the private placement of negotiable securities should be conducted within one year from the date of the shareholder meeting resolution.
Considering that the issuance period will soon reach the deadline, the issue of common shares by private placement approved by the 2023 annual general meeting will not continue from now till the deadline after the board resolution.

IV. Adoption:

No. 1: (Proposed by the Board of Directors)

Subject: Present the Company’s 2023 business report and financial statements for ratification.

Explanation: (I) The 2023 business report and financial statements were approved by the Audit Committee and the Board of Directors, where the financial statements have been audited and completed by CPAs Ya-Hui Cheng and Chien-Yu Liu from PricewaterhouseCoopers Taiwan.
(II) The business report, independent auditor’s report, and financial statements are available in Attachment 1, Attachment 4 and Attachment 5.

Resolution: The voting results of the motion are shown as follows. The number of votes in favor of the motion exceeded the statutory amount, and the motion was approved. The results of the voting are as follows:

Total voting rights at the time of voting	Results of voting	Results of voting	Results of voting	Shares of voting rights of shareholde rs present (%)
130,066,176 shares	Number in favor: (Voting rights exercised by electronic means:	129,074,118 18,369,810	shares shares)	99.23%
	Number against: (Voting rights exercised by electronic means:	73,322 28,322	shares shares)	0.05%
	Invalid:	0	shares	0.00%
	Abstention/Did not vote: (Voting rights exercised by electronic means:	918,736 918,736	shares shares)	0.70%

No. 2: (Proposed by the Board of Directors)

Subject: Present the Company’s 2023 profit distribution for ratification.

Explanation: The Company’s 2023 earnings distribution proposal has been approved by the Audit Committee and the Board of Directors, and please refer to Attachment 6 of this Handbook for the earnings distribution schedule.

Resolution: The voting results of the motion are shown as follows. The number of votes in favor

of the motion exceeded the statutory amount, and the motion was approved. The results of the voting are as follows:

Total voting rights at the time of voting	Results of voting	Results of voting	Results of voting	Shares of voting rights of shareholders present(%)
130,066,176 shares	Number in favor: (Voting rights exercised byelectronic means:	129,056,577 18,352,269	shares shares)	99.22%
	Number against: (Voting rights exercised byelectronic means:	92,963 47,963	shares shares)	0.07%
	Invalid:	0	shares	0.00%
	Abstention/Did not vote: (Voting rights exercised byelectronic means:	916,636 916,636	shares shares)	0.70%

V. Discussion topics

No. 1: (Proposed by the Board of Directors)

Subject: Present amendments to provisions of the Company’s Article of Incorporation for deliberation.

Explanation: In response to the Company’s operation, it is proposed to amend the provisions of the Articles of Incorporation. For the comparison table of the amended provisions, please refer to Attachment 7. Resolution: The voting results of the motion are shown as follows. The number of votes in favor of the motion exceeded the statutory amount, and the motion was approved. The results of the voting are as follows:

Total voting rights at the time of voting	Results of voting	Results of voting	Results of voting	Shares of voting rights of shareholders present (%)
130,066,176 shares	Number in favor: (Voting rights exercised by electronic means:	129,067,627 18,363,319	shares shares)	99.22%
	Number against: (Voting rights exercised by electronic means:	82,391 37,391	shares shares)	0.06%
	Invalid:	0	shares	0.00%
	Abstention/Did not vote: (Voting rights exercised by electronic means:	916,158 916,158	shares shares)	0.70%

No. 2: (Proposed by the Board of Directors)

Subject: Private placement of marketable securities, submitted for resolution.

[Explanation]: (I) In order to increase the Company’s working capital, and/or to expand the plant and purchase machinery and equipment to improve operational scaling and/or to repay loans to improve the Company’s financial structure and/or to better respond to other funding needs for the long-term development of the Company, the Company intends to issue ordinary shares or domestic convertible bonds through private placement in accordance with the provisions set forth in Article 43-6 of the Securities and Exchange Act. The total number of shares to be issued will not exceed 75,000 thousand shares (including the number of ordinary shares converted from domestic convertible bonds at the conversion

price on the day of the private placement), with a par value of NT$10 per share. It is intended to propose to the shareholders’ meeting to authorize the Board of Directors to, depending on the market conditions and the Company’s actual capital and operational needs, conduct the private placement at an appropriate time in one to three installments, using a single method or a combination of methods, within one year from the date of the resolution being adopted at the shareholders’ meeting.

(II) The private placement shall, in accordance with Article 43-6 of the Securities and Exchange Act, be justified as follows:
The basis and reasonableness of the private placement price:
- A. Private placement of common shares
  - The issue price of this private placement of common shares should be not less than 80% of the reference price’ is the basis for the determining the private placement price or that the ‘issue price. The reference price is set based on the higher of the following two standards:
  - a. Calculate the simple average of the closing price of the common stock 1, 3, or 5 business days prior to the pricing day, deduct the ex-right and ex-dividend shares of the stock dividend, and add the stock price after decapitalization and reversal of the ex-right.
  - b. The simple average of the closing price of the common stock for the 30 business days prior to the pricing day minus the ex-right and ex-dividend shares paid as dividend, plus the stock price after decapitalization and reversal of ex-right.
- B. Private placement of domestic unsecured convertible bonds
  - a. Denomination: NT$100,000 or an integer multiple thereof.
  - b. Issue period: Not more than five years from the date of issue. c. Coupon rate: 0%
  - d. The price for issuing domestic convertible bonds shall not be lower than 80% of the theoretical price. The pricing model of the theoretical price shall, as a whole, encompass and include the concurrent consideration of the various rights included in the terms of issuance. The conversion price shall not be lower than 80% of the price determined by the following calculation, whichever is higher:
    - (1) The share price, after deducting the value of bonus shares issued as stock dividends and cash dividends and adding back the value of the shares canceled in connection with
6 -

capital reduction, based on the simple arithmetic average of the closing price of the ordinary shares of the Company on the first, third or fifth trading day prior to the pricing date.

  - (2) The simple arithmetical average closing price of the ordinary shares of the Company for thirty trading days prior to the pricing date after deducting the value of bonus shares issued as stock dividends and cash dividends, and adding back the value of the shares canceled in connection with capital reduction.

C. The actual private placement price and the actual pricing date are proposed to be set by the shareholders’ meeting within the range of the resolution, and the board of directors authorized to determine said price based on market and company conditions and the situation of the selected strategic investors. The basis for the above-mentioned private placement price complies with the provisions of "Notes for Public Companies Conducting Private Placements of Securities" and thus should be reasonable.
The method, purpose, necessity, and expected benefits of selecting the specific entity:
The subjects of the Private Placement are limited to the specified entity in compliance with Article 43-6 of the Securities and Exchange Act. Potential entity include banking, bills, trust, insurance, securities or other legal persons or institutions approved by the competent authority, Strategic investors of natural persons, legal persons, or funds who meet the conditions set by the competent authority, who have a substantial understanding of the Company’s operations or industry development, and who will directly or indirectly benefit the Company’s future operations, but have not yet determined entity.
The selection of the offerees is necessary and is made in response to the needs of the Company’s operations and development, and it is intended that the offerees directly or indirectly assist the Company in finance, business, production, technology, procurement, management, strategy, industry integration, or sustainable development, in order to strengthen the Company’s competitiveness and improve operational efficiency and long-term development, which should be beneficial in enhancing the Company’s competitiveness and shareholders’ equity. It is intended to authorize the board of directors to review the relevant qualifications of the offerees’.
7 -
Reasons for conducting the private placement: Private placement is a quick and easy way to introduce strategic investors. Private placement of securities has transfer restrictions and can better ensure long-term cooperation between the company and strategic investors. In addition, the board of directors being authorized to determine the actual operational needs of the company to be fulfilled by the private placement will also effectively improve the agility and flexibility of the Company’s fund-raising.
Use of funds and expected benefits: The funds raised from each private placement are used to replenish working capital, and/or expand plants and purchase machinery and equipment to increase the scale of operations, and/or repay loans to build a complete financial structure, and/or support other capital requirements for the Company’s long-term development. Each private placement and the use of funds after the completion of the private placement is expected to strengthen the company’s competitiveness and improve operational efficiency, as well as promoting the company’s stable growth, improving the company’s competitiveness and being beneficial to shareholders’ equity.
(III) The rights and obligations of this private placement of common shares or common shares converted from domestic convertible corporate bonds are the same as those of the common shares already issued by the Company; however, in accordance with Article 43-8 of the Securities and Exchange Act, the private placement of securities is after three years from the date of delivery, the private placement of the securities may be reported to the competent authority after three years from the delivery date and after obtaining the consent letter from the Taiwan Stock Exchange for the issuance of listing standards in accordance with the relevant laws and regulations and application for listing and trading.
(IV) In this private placement of common shares or issuance of domestic convertible corporate bonds, it is intended that the shareholders’ meeting authorize the Chairman, or a person designated by the Chairman, sign and negotiate all contracts and documents related to this private placement on behalf of the Company and to handle all matters related to the private placement plan on behalf of the Company.
(V) The number of shares issued, issue price, issuing conditions, capital increase record date, planned items, progress of fund utilization, expected benefits and other matters from the private placement of ordinary shares or domestic convertible corporate bonds, and other matters that are not yet addressed in the
8 -

private placement of ordinary shares or domestic convertible corporate bonds. The shareholders’ meeting authorized the Board of Directors to formulate and implement regulations based on market conditions and the Company’s operational needs. The Board of Directors is authorized to make future amendments in accordance with the requirements of the competent authorities or changes in the objective environment.

Supplementary Note: A letter from shareholder account No. 134862, Securities and Futures Investors Protection Center, requesting the Company to explain to its shareholders the purpose of the private placement and the impact on the managerial control.

(I) Purpose of private placement:
The purpose of the private placement is to draw strategic investors, and there are restrictions on the transfer of private placement stocks, which can ensure a long-term collaborative relationship between the Company and strategic investors. Authorizing the board to conduct private placement in response to the actual needs of the Company can also effectively improve the liquidity and flexibility of the Company’s financing.
(II) No significant impact on managerial control and shareholders’ equity: The private placement will issue no more than 75,000 thousand shares (including the number of ordinary shares converted from domestic convertible bonds at the conversion price on the day of the private placement). It is intended to propose to the shareholders’ meeting to authorize the Board of Directors to, depending on the market conditions and the Company’s actual capital and operational needs, conduct the private placement at an appropriate time in one to three installments, using a single method or a combination of methods, within one year from the date of the resolution being adopted at the shareholders’ meeting. If fully raised, the Company’s paid-in capital will reach NT$3.5178 billion (including the current paid-in capital, full conversion of convertible bonds, and all the funds raised in the private placement). Privately placed equity will only account for 21.32% of the paid-in share capital, and the purpose of the private placement is to draw strategic investors. The private placement will be conducted once or in separate issues within one year from the date of the resolution being adopted at the shareholders’ meeting, so it will not have a significant change and impact on the managerial control and shareholders’ equity.

Please be informed of the above supplementary note.

Total voting rights at the time of voting	Results of voting	Results of voting	Results of voting	Shares of voting rights of shareholders present (%)
130,066,176 shares	Number in favor: (Voting rights exercised by electronic means:	116,089,282 5,384,974	shares shares)	89.25%
	Number against: (Voting rights exercised by electronic means:	12,985,812 12,940,812	shares shares)	9.98%
	Invalid:	0	shares	0.00%
	Abstention/Did not vote: (Voting rights exercised by electronic means:	991,082 991,082	shares shares)	0.76%

VI. Extempore motions

Summary of question from shareholder account number 190053:

Media reported that Mask’s revenue will reach US$1 billion. How is this achieved?
The largest shareholder of Mask is 100% invested Youe Chung Capital Corporation. What is its legitimacy?

The persons designated by the chairperson replied as follows:

General Manager replied, “According to media reports, Taiwan Mask strives to achieve US$1

billion of revenue. This is a milestone goal, rather than this year’s goal, for the Company. Despite recession in the global photomask industry in 2023, the Company’s photomask business maintained growth. However, our subsidiaries are still in the sprinting stage, resulting in a decline in the Company’s consolidated profit compared to the previous year. Our subsidiaries have been on truck, and our profit will return to growth.”
CFO replied, “The shares of the Company held by Youe Chung Capital Corporation, the largest shareholder of the Company, were acquired through mergers in previous years, not bought back from the market, and were approved by the competent authority. All of these shares are in compliance with the laws and regulations."
10 -
VII. End of meeting: At 09:38 a.m. on the same day, the chairperson announced the end of the meeting.
(The meeting minutes recorded the essentials and results of the meeting in accordance with the provisions of Paragraph 4, Article 183 of the Company Act. The actual content, procedures and shareholder speeches during the meeting are subject to the audio and video recordings of the meeting.)
11 -

[Attachment 1]

Taiwan Mask Corporation 2023 Business Report

To begin with, I would like to express my appreciation to all shareholders for their support. Due to continued international turbulence (geopolitics, the Russo-Ukrainian war, the Israel-Palestine conflict) and inflationary factors, governments around the world have to combat inflationary pressure and sluggish consumption after the lockdowns are lifted. The destocking speed of the global semiconductor and electronics industries is not as good as expected. Although there is the topic of AI applications, under the slowdown of demand for consumer products with a large proportion of semiconductors, the scale of the global semiconductor market declined in 2023. However, it will return to growth in 2024 and a double-digit growth is expected. Overall, the difference between semiconductor process technologies and applications will result in a different end demand. In this regard, Taiwan Mask has a stable deployment to prudently plan for new capacity and new technologies in response to overall needs in a timely and appropriate manner, so as to grow together with strategic partners. At the same time, we will continue to strengthen operational management efficiency, deepen customer relationship management and services, and continue to grow together with strategic customers.

In the face of the downturn of the global semiconductor market, with the successful deployment of medium-end and high-end mask manufacturing services, the expansion of mask OEM services for strategic partners, and the endeavor of the management team and all the employees, the Company has maintained steady growth in its operations in 2023, with annual parent company only net revenue amounting to NT$3.986 billion, up by 2.5% compared to the previous year; the net profit after tax amounted to NT$366 million. In terms of operational performance, we continued to improve technology and manufacturing quality, and won the recognition and long-term support of our strategic customers by reducing costs, deepening customer service, shortening delivery time, and improving customer satisfaction.

TMC continues to grow in its core business and expand its strategic deployment. In addition, the group’s subsidiaries also focus on the development of their own core businesses and expand related synergistic businesses in order to create maximum benefits.

Looking forward to 2024, in response to the growth of the semiconductor market, TMC will,

Continue to strengthen its operations, strengthen customer satisfaction and loyalty, build the production capacity and accept orders of high-end process photomasks, lower manufacturing cost, optimize customer service, and maximize performance of current production lines.
Continue to expand the photomask business required for 40nm technology for 12-inch wafers: After the successful mass production of 65/55photomasks, we will actively expand photomask manufacturing services for 12-inch wafer fabs in 2024 and introduce the mass production of 40nm photomask and plan investment in manufacturing technology and production services
12 -

for 28nm photomasks.

The Group’s synergy integration and full performance: Under the foundation of photomask service by the parent company, combining with its subsidiaries, including Miracle Tech’s foundry management service, Aptos Tech’s packaging and testing service, Xsense Tech’s heat dissipation substrate production, Innova Vision's contact lens manufacturing, DIGITAL-CAN TECH’s laminate manufacturing, Baile’s all-round energy solutions of energy generation and energy storage provided, and Moment semiconductor’s self-owned brand consumer electronic products, there are expectations to create more values for shareholders through the Group’s internal collaborations and the comprehensive resources management.
Continue the implementation of sustainable development: Taiwan Mask adheres to the business philosophy of “respect for the nature, love for people, and protect the planet” and develops its business in the three major fields of semiconductor, green energy, and smart manufacturing. We pursue sustainable development with energy creation and energy conservation. By focusing on core business development, managing the Group’s total resources, aiming at innovation and sustainability, and working with strategic customers, suppliers, subsidiaries of the Group, and stakeholders to integrate resources, we will continue to invest in sustainability issues and implement sustainable development.

Best wishes to all valued shareholders.

Chairman: Manager: Accounting Officer:

13 -

[Attachment 2]

Taiwan Mask Corporation

Audit Committee’s Audit Report

We have reviewed the Company’s 2023 business report, financial statements and earnings distribution proposal prepared by the board of directors. The financial statements have been audited by CPA Ya-Hui Cheng and CPA Chien-Yu Liu of PricewaterhouseCoopers Taiwan, to which the firm has issued an independent auditor's report. The Audit Committee found no misstatement in the above, and hereby presents this report in accordance with Article 14-4 of the Securities and Exchange Act and Article 219 of the Company Act.

For

The 2024 Annual General Meeting

==> picture [97 x 93] intentionally omitted <==

Taiwan Mask Corporation

==> picture [59 x 70] intentionally omitted <==

Audit Committee convener: Wei-Chen Wang

March 6, 2024

14 -

[Attachment 3]

Endorsement and guarantee of the Company and its subsidiaries for 2023

Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023

		Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023	Taiwan Mask Corporation and Subsidiaries Endorsements and Guarantees to Others January 1 to December 31, 2023
Table 2		Unit: NTD in thousand (Unless otherwise specified) Guaranteed Party Limit of endorsement and guarantee for a single enterprise (Note 3, 4, 5, 6) Maximum Balance of Endorsement/ Guarantee for the Period Ending Balance of Endorsement/ Guarantee Amount Actually Drawn Amount of Endorsement/ Guarantee Collateralized by Properties Ratio of Accumulated Endorsement/ Guarantee to Net Equity per Latest Financial Statements Maximum Endorsement/ Guarantee Amount Allowable (Note 3,4,5,6) Guarantee Provided by Parent Company to Subsidiary Guarantee Provided by Subsidiary to Parent Company Guarantee Provided by Subsidiaries in Mainland China Note Name of Company Relationship (Note 2) Miracle Technology CO., LTD. 2 $ 229,550 $ 226,975 $ 214,935 $ - $ - 4.43% $ 2,049,257 Y N N Note 3 Aptos Technology INC. 3 20,493 19,500 - - - 0.00% 20,493 N Y N Note 4 Miracle Technology CO., LTD. 3 392,131 226,695 224,165 224,165 224,165 57.17% 392,131 N Y N Note 5 Xsense Technology 1 174,394 150,000 150,000 150,000 150,000 34.40% 174,394 N N N Note 6 Aptos Technology INC. 1 174,394 20,000 20,000 20,000 20,000 4.59% 174,394 N N N Note 6 ADL Energy Corp 1 157,182 50,000 30,000 30,000 30,000 7.63% 157,182 N N N Note 7
No. (Note 1)	Endorser/ guarantor		Guaranteed Party		Limit of endorsement and guarantee for a single enterprise (Note 3, 4, 5, 6)	Maximum Balance of Endorsement/ Guarantee for the Period	Ending Balance of Endorsement/ Guarantee	Amount Actually Drawn	Amount of Endorsement/ Guarantee Collateralized by Properties	Ratio of Accumulated Endorsement/ Guarantee to Net Equity per Latest Financial Statements	Maximum Endorsement/ Guarantee Amount Allowable (Note 3,4,5,6)	Guarantee Provided by Parent Company to Subsidiary	Guarantee Provided by Subsidiary to Parent Company	Guarantee Provided by Subsidiaries in Mainland China	Note
			Name of Company	Relationship (Note 2)
0 1 2 3 3 4	Taiwan Mask Corporation ADL Energy Corp Miko-China Enterprise (Shanghai) Co., Ltd. Miracle Technology CO., LTD. Miracle Technology CO., LTD. Pilot Battery Co., Ltd.		Miracle Technology CO., LTD. Aptos Technology INC. Miracle Technology CO., LTD. Xsense Technology Aptos Technology INC. ADL Energy Corp	2 3 3 1 1 1	$ 229,550 20,493 392,131 174,394 174,394 157,182	$ 226,975 19,500 226,695 150,000 20,000 50,000	$ 214,935 - 224,165 150,000 20,000 30,000	$ - - 224,165 150,000 20,000 30,000	$ - - 224,165 150,000 20,000 30,000	4.43% 0.00% 57.17% 34.40% 4.59% 7.63%	$ 2,049,257 20,493 392,131 174,394 174,394 157,182	Y N N N N N	N Y Y N N N	N N N N N N	Note 3 Note 4 Note 5 Note 6 Note 6 Note 7

Note 1: The description of the number columns are as follows:

(1) Fill in “0” for the issuer.

(2) The investee company is numbered in sequence starting from the Arabic numeral 1 according to company type.

Note 2: The relationship between the guarantor and the guarantee are one of the seven types indicated below:

(1) A company with which it does business.

(2) A company in which the Company directly and indirectly holds more than 50% of the voting shares.

(3) A company that directly and indirectly holds more than 50% of the voting shares in the Company.

(4) Companies in which the Company holds, directly or indirectly, 90%, or more of the voting shares may make endorsements/guarantees for each other.

(5) A company that is mutually insured by a contract between peers or co-founders based on the needs of the contracted work.

(6) A company that is guaranteed by all contributing shareholders in proportion to their shareholdings due to a joint investment relationship.

(7) Companies that are engaged in joint and several guarantees for the performance guarantee of pre-sale housing sales contracts in accordance with the regulations of the Consumer Protection Act.

Note 3: The Company’s endorsement and guarantee practices for others provide that:

(1) The total amount of the Company’s external endorsement guarantee shall not exceed 30% of the Company’s paid-in capital.

(2) The amount of business transactions refers to the higher of the amount of goods purchased or sold between the parties.

(3) Companies with which the Company has a parent-child relationship: The endorsement and guarantee for a single enterprise shall not exceed 10% of the Company’s paid-in capital and the company’s paid-in capital being endorsed and guaranteed.

(4) The aggregate amount of the endorsement and guarantee of the Company and its subsidiaries as a whole shall not exceed 40% of the net worth of the Company, of which the endorsement and guarantee of a single subsidiary shall not exceed 20% of the net worth of the Company.

Note 4: Subsidiary - ADL Energy Corp Endorsement and Guarantee Procedures:

(1) The aggregate amount of cumulative external endorsement guarantees shall not exceed 40% of the net value of the Company’s most recent audited or reviewed financial statements.

(2) The amount of the endorsement guarantee for a single enterprise shall not exceed 30% of the net value of the company’s most recent audited or reviewed financial statements.

(3) The Company and its subsidiaries shall state in the shareholders’ meeting the necessity and reasonableness of any endorsement or guarantee of more than 50% of the net value of the Company’s most recent audited or reviewed financial statements.

Note 5: Miko-China Enterprise (Shanghai) Co., Ltd. Endorsement and Guarantee Procedures:

The total amount of endorsement guarantee liability is limited to RMB 30 million, and the amount of endorsement guarantee for a single enterprise shall not exceed RMB 30 million; however, for the parent company that directly or indirectly holds, through a subsidiary, more than 50% of the common stock equity of a company, it may endorse up to its net value.

Note 6: Subsidiary - Miracle Technology Co., Ltd. Endorsement and Guarantee Procedures:

The aggregate amount of cumulative external endorsement guarantees shall not exceed 40% of the net value of the Company’s most recent audited or reviewed financial statements.

Note 7: Subsidiary - Pilot Battery Co.,Ltd. Endorsement and Guarantee Procedures:

The aggregate amount of cumulative external endorsement guarantees shall not exceed 40% of the net value of the Company’s most recent audited or reviewed financial statements.

15 -

[Attachment 4]

Independent Auditors ’ Report

(113) Tsai-Sheng-Bao-Zi No. 23002830

To Taiwan Mask Corporation,

Opinions

We have audited the accompanying consolidated balance sheets of Taiwan Mask Corporation and its subsidiaries (the “Group”) as of December 31, 2023 and 2022, and the related consolidated statement of comprehensive income, of changes in equity and of cash flows for the years ended December 31, 2022 and 2021, and notes to the consolidated financial statements, including a summary of significant accounting policies.

In our opinion, based on our audits and the reports of the other independent auditors, as described in the Other matters section of our report, the accompanying consolidated financial statements present fairly, in all material aspects, the consolidated financial position of the Group as of December 31, 2023 and 2022, and its consolidated financial performance and its consolidated cash flows for the years ended December 31, 2023 and 2022 in accordance with the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations as endorsed by the Financial Supervisory Commission.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards generally accepted in Taiwan. Our responsibilities under those standards are further described in the Independent Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the Code of Professional Ethics for Certified Public Accountants in the Republic of China (the “Code”), and we have fulfilled our other ethical responsibilities in accordance with the Code. Based on our audits and the reports of the other independent auditors, we believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements of fiscal year 2023. These matters were addressed in the context of our audit of the consolidated financial statements as a whole and, in forming our opinion thereon, we do not provide a separate opinion on these matters.

Key audit matters for the TMC Group’s consolidated financial statements in fiscal year 2023 are

16 -

stated as follows:

Evaluation of Inventories

Explanation

Refer to Note 4(14) for the accounting policies on the evaluation of inventories, Note 5(2) for the uncertainty of accounting estimations and assumptions for evaluation of inventories, and Note 6(5) for the detailed description of inventory accounts. The inventory amount and allowance for inventory valuation loss as of December 31, 2023 were NT$805,951 thousand and NT$104,128 thousand, respectively.

The Group is primarily engaged in mask and integrated circuit services in the semiconductor industry. Due to rapid technological innovations, short life-cycle and competition within the mask industry, the risk of price fluctuations, Loss on decline in value of inventories and obsolescence is higher than that of other industries. Management evaluates inventories stated at the lower of cost and net realizable value. Since the evaluation of inventories is subject to management’s judgment and the accounting estimations will have significant influence on the inventory values, the evaluation of inventories has been identified as one of the key audit matters.

How our audit addressed the matter

We have performed primary audit procedures for the above matter as follows:

Understand and evaluate the accounting policy for the provision of allowance for losses on decline in value of inventories.
Perform test to evaluate the ageing statement of inventories and the statement of lower of cost and net realizable value of inventories, including validating the supporting documents related to the date of inventory movement to confirm the correct ageing classification, and validating the supporting documents related to the net realizable value to assess and confirm the reasonableness of the net realizable value determination.
Verify the reasonableness of allowance for inventory valuation loss.

Income recognition

Explanation

For the accounting policy on income recognition, please refer to Note 4(29) of the financial report. For sales revenue, please refer to Note 6(22); the operating income in fiscal year 2023 was NT$7,199,935 thousand.

The Group mainly produces and sells products such as masks and integrated circuits used in semiconductors, and has a large and diversified sales base. Trading conditions vary according to market conditions and customer needs. Considering that sales revenue is a major transaction that has a

17 -

significant impact on the consolidated financial statements, we believe that the recognition of sales revenue is one of the most important matters to be considered in this year’s audit.

How our audit addressed the matter

We have performed primary audit procedures for the above matter as follows:

1.Understand the type of major income and assess internal operations, review revenue recognition and accounting treatment.
2.Obtain the sales revenue statement, sample the sales transactions and verify the relevant documents to determine the appropriateness of the sales revenue.
3.Execute the cut-off test for the sales receipts transaction for a certain period of time before and after the closing date, and confirm that the account is correct at the time of entry.

Other matters–Parent company only financial reports

We have audited and expressed an unmodified opinion on the parent company only standalone financial statements of Taiwan Mask Corporation as of and for the years ended December 31, 2023 and 2022.

Responsibilities of management and those charged with governance for the consolidated financial statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations as endorsed and issued into effect by the Financial Supervisory Commission, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the Audit Committee, are responsible for overseeing the Group’s financial reporting process.

18 -

Independent Auditor’s responsibilities for the audit of the consolidated financial statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors’ Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ROC AS will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit conducted in accordance with ROC AS, we exercise professional judgment and professional skepticism throughout the audit. We also conduct the following undertakings:

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our report. However, future events or conditions may cause the Group to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision, and performance of the group audit.
19 -

We remain solely responsible for our audit opinion.

We communicated with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit for the current period.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the 2023 consolidated financial statements of the current period and are therefore deemed key audit matters. We describe these matters in our Auditors’ Report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our auditor’s report because the adverse consequences of doing so would reasonable are expected to outweigh the public interest benefits of such communication.

PricewaterhouseCoopers Taiwan

Ya-Hui Cheng

Accountant

Chien-Yu Liu

Securities and Futures Bureau of Financial Supervisory Commission of the Executive Yuan

Approval Certificate No. 0960072936

Financial Supervisory Commission of the Executive Yuan

Approval Document for Attestation: Jin-Guan-Zheng-Shen-Zi No. 1090350620

March 6, 2024

20 -

Taiwan Mask Corporation and Subsidiaries Consolidated Balance Sheet December 31, 2023 and 2022

Assets	Notes 6(1) 6(2) and 8 6(3) and 8 6(22) 6(4) 6(4) 6(4) and 7 7 6(5) 6(2) and 8 6(3) and 8 6(6) and 7 6(7) and 8 6(8) 6(10) and 8 6(11) and 8 6(29) 6(12)	December31,2023 Amount % $ 1,364,106 7 1,626,536 8 259,885 1 105,263 - 6,049 - 1,478,806 7 26 - 29,003 - 407 - 1,830 - 701,823 3 326,387 2 10,774 - 5,910,895 28 2,896,178 14 660,157 3 67,506 - 9,405,807 45 554,630 3 170,500 1 721,410 3 22,337 - 514,639 3 15,013,164 72 $ 20,924,059 100	Unit: NT$Thousand December31,2022 Amount % $ 1,749,957 10 1,584,598 9 160,465 1 140,231 1 1,361 - 1,501,012 8 2,346 - 13,751 - - - 42,652 - 382,530 2 280,245 2 44,734 - 5,903,882 33 2,896,557 16 507,602 3 124,565 1 5,883,661 33 550,611 3 170,346 1 497,180 3 9,365 - 1,349,137 7 11,989,024 67 $ 17,892,906 100
		Amount $ 1,364,106 1,626,536 259,885 105,263 6,049 1,478,806 26 29,003 407 1,830 701,823 326,387 10,774 5,910,895 2,896,178 660,157 67,506 9,405,807 554,630 170,500 721,410 22,337 514,639 15,013,164 $ 20,924,059	Amount $ 1,749,957 1,584,598 160,465 140,231 1,361 1,501,012 2,346 13,751 - 42,652 382,530 280,245 44,734 5,903,882 2,896,557 507,602 124,565 5,883,661 550,611 170,346 497,180 9,365 1,349,137 11,989,024 $ 17,892,906
Current assets 1100 Cash and Cash Equivalents 1110 Financial Assets at Fair Value Through Profit or Loss - Current 1136 Financial Assets at Amortized Cost - Current 1140 Contract Asset - Current 1150 Notes Receivables (Net) 1170 Accounts Receivables (Net) 1180 Accounts Receivables - Related Parties (Net) 1200 Other Receivables 1210 Other Receivables - Related Parties 1220 Tax Assets for the Period 130X Inventories 1410 Prepayments 1470 Other Current Assets 11XX Total Current Assets Non-Current Assets 1510 Financial Assets at Fair Value Through Profit or Loss - Non Current 1535 Financial Assets at Amortized Cost - Non Current 1550 Investment under Equity Method 1600 Property, plant and equipment 1755 Right-of-use Asset 1760 Investment property (Net) 1780 Intangible assets 1840 Deferred Income Tax Assets 1900 Other Non-Current Assets 15XX Total Non-Current Assets 1XXX Total Assets

(continued on next page)

21 -

Taiwan Mask Corporation and Subsidiaries Consolidated Balance Sheet December 31, 2023 and 2022

Liabilities and Equities	Unit: NT$Thousand December 31,2023 December 31,2022 Notes Amount % Amount % 6(13) $ 5,429,370 26 $ 4,624,525 26 6(2) 9,383 - 5,697 - 6(22) 174,538 1 232,778 1 66 - 81 - 463,892 2 417,175 2 7 - - 284 - 6(14) 1,205,153 6 837,213 5 7 304 - - - 15,379 - 178,854 1 4,513 - - - 47,439 - 32,571 - 6(16) 1,216,216 6 611,473 4 57,651 - 39,114 - 8,623,904 41 6,979,765 39 6(15) 3,424,600 16 2,609,044 14 6(16) 3,126,340 15 3,167,974 18 6(29) 127,215 1 121,124 1 519,754 3 527,098 3 6(17) 10,648 - 16,512 - 42,282 - 34,754 - - - 2,428 - 7,250,839 35 6,478,934 36 15,874,743 76 13,458,699 75 6(18) 2,564,465 12 2,564,465 14 6(19) 1,439,959 7 1,251,681 8 6(20) 827,460 4 769,952 4 1,464,101 7 1,729,293 10 6(21) 1,641 - 10,508 - 6(18) and 8 ( 1,174,484 ) ( 6 ) ( 1,778,979) ( 10) 5,123,142 24 4,546,920 26 ( 73,826 ) - ( 112,713) ( 1) 5,049,316 24 4,434,207 25 9 11 $ 20,924,059 100 $ 17,892,906 100
Current liabilities 2100 Short Term Loans 2120 Financial liabilities at fair value through profit or loss - Current 2130 Contract Liabilities - Current 2150 Notes Payable 2170 Accounts Payable 2180 Accounts payable - Related party 2200 Other Payables 2220 Other Payables - Related Parties 2230 Current Income Tax Liabilities 2250 Provision for Liabilities - Current 2280 Lease Liability - Current 2320 Long-term liabilities due within one year or one business cycle 2399 Other Current Liabilities - Other 21XX Total Current Liabilities Non-current liabilities 2530 Corporate bonds payable 2540 Long-term borrowings 2570 Deferred Income Tax 2580 Lease liability - Non Current 2640 Defined Benefit Liabilities - Non Current 2645 Guarantee Deposits Received 2670 Other Non-Current Liabilities - Other 25XX Total Non-Current Liabilities 2XXX Total Liabilities Equity attributable to shareholders of the parent company Capital 3110 Capital stock Capital surplus 3200 Capital surplus Retained earnings 3310 Legal reserve 3350 Unappropriated earnings Other equity interests 3400 Other equity interests 3500 Treasury stock 31XX Total Equities Attributable to Parent Company 36XX Non-controlling Interests 3XXX Total Equities Major Commitments and Contingencies Major Events after Financial Statement Date 3X2X Total Liabilities and Equities

Liabilities and Equities

Unit: NT$Thousand
December 31,2023

December 31,2022
Notes
Amount
%
Amount
%
6(13)
$ 5,429,370
26
$ 4,624,525
26
6(2)
9,383
-
5,697
-
6(22)
174,538
1
232,778
1
66
-
81
-
463,892
2
417,175
2
7
-
-
284
-
6(14)
1,205,153
6
837,213
5
7
304
-
-
-
15,379
-
178,854
1
4,513
-
-
-
47,439
-
32,571
-
6(16)
1,216,216
6
611,473
4
57,651
-
39,114
-
8,623,904
41
6,979,765
39
6(15)
3,424,600
16
2,609,044
14
6(16)
3,126,340
15
3,167,974
18
6(29)
127,215
1
121,124
1
519,754
3
527,098
3
6(17)
10,648
-
16,512
-
42,282
-
34,754
-
-
-
2,428
-
7,250,839
35
6,478,934
36
15,874,743
76
13,458,699
75
6(18)
2,564,465
12
2,564,465
14
6(19)
1,439,959
7
1,251,681
8
6(20)
827,460
4
769,952
4
1,464,101
7
1,729,293
10
6(21)
1,641
-
10,508
-
6(18) and 8
(
1,174,484 ) (
6 ) (
1,778,979) (
10)
5,123,142
24
4,546,920
26
(
73,826 )
- (
112,713) (
1)
5,049,316
24
4,434,207
25
9
11
$ 20,924,059
100
$ 17,892,906
100

Current liabilities
2100
Short Term Loans
2120
Financial liabilities at fair value
through profit or loss - Current
2130
Contract Liabilities - Current
2150
Notes Payable
2170
Accounts Payable
2180
Accounts payable - Related party
2200
Other Payables
2220
Other Payables - Related Parties
2230
Current Income Tax Liabilities
2250
Provision for Liabilities - Current
2280
Lease Liability - Current
2320
Long-term liabilities due within one
year or one business cycle
2399
Other Current Liabilities - Other
21XX
Total Current Liabilities
Non-current liabilities
2530
Corporate bonds payable
2540
Long-term borrowings
2570
Deferred Income Tax
2580
Lease liability - Non Current
2640
Defined Benefit Liabilities - Non
Current
2645
Guarantee Deposits Received
2670
Other Non-Current Liabilities - Other
25XX
Total Non-Current Liabilities
2XXX
Total Liabilities
Equity attributable to shareholders of
the parent company
Capital
3110
Capital stock
Capital surplus
3200
Capital surplus
Retained earnings
3310
Legal reserve
3350
Unappropriated earnings
Other equity interests
3400
Other equity interests
3500
Treasury stock
31XX
Total Equities Attributable to
Parent Company
36XX
Non-controlling Interests
3XXX
Total Equities
Major Commitments and Contingencies
Major Events after Financial Statement
Date
3X2X
Total Liabilities and Equities

The accompanying notes are an integral part of the consolidated financial statements.

Managerial Officer: Lidon Chen

Accounting Supervisor: Eve Yang

Chairman: Sean Chen

-22-

Taiwan Mask Corporation and Subsidiaries Consolidated Comprehensive Income Statement January 1 to December 31, 2023, and 2022

Unit: NT$Thousand (Except for earnings per share)

Items	2023 2022 Notes Amount % Amount % 6(22) and 7 $ 7,199,935 100 $ 7,741,118 100 6(5) and 7 ( 5,363,566) ( 75) ( 5,642,493) ( 73) 1,836,369 25 2,098,625 27 6(27) (28) and 7 ( 271,119) ( 4) ( 209,947) ( 3) ( 459,028) ( 6) ( 375,754) ( 5) ( 348,136) ( 5) ( 254,090) ( 3) 12(2) ( 9,455) - ( 10,558) - ( 1,087,738) ( 15) ( 850,349) ( 11) 748,631 10 1,248,276 16 6(23) 40,742 - 25,271 - 6(24) and 7 133,843 2 258,255 4 6(25) ( 98,389) ( 1) ( 619,247) ( 8) 6(26) ( 293,238) ( 4) ( 177,546) ( 2) 6(6) ( 85,789) ( 1) ( 61,296) ( 1) ( 302,831)( 4) ( 574,563)( 7) 445,800 6 673,713 9 6(29) ( 281,516) ( 4) ( 228,081) ( 3) $ 164,284 2 $ 445,632 6
4000 Operating income 5000 Operating costs 5900 Gross profit Operating Expenses 6100 Selling Expenses 6200 Administrative Expenses 6300 R&D Expenses 6450 Expected loss on credit impairment 6000 Total Operating Expenses 6900 Operating profit Non-operating income and expenses 7100 Interest income 7010 Other Incomes 7020 Other Gains and Losses 7050 Financial Costs 7060 The share of affiliates and joint venture profits and losses recognized by the equity method 7000 Total Non-Operating Incomes and Losses 7900 Earnings Before Tax 7950 Income Tax Expense 8200 Net profit for the period

Items

2023
2022
Notes
Amount
%
Amount
%
6(22) and 7
$ 7,199,935
100
$ 7,741,118
100
6(5) and 7
(
5,363,566) (
75) (
5,642,493) (
73)
1,836,369
25
2,098,625
27
6(27)
(28) and 7
(
271,119) (
4) (
209,947) (
3)
(
459,028) (
6) (
375,754) (
5)
(
348,136) (
5) (
254,090) (
3)
12(2)
(
9,455)
- (
10,558)
-
(
1,087,738) (
15) (
850,349) (
11)
748,631
10
1,248,276
16
6(23)
40,742
-
25,271
-
6(24) and 7
133,843
2
258,255
4
6(25)
(
98,389) (
1) (
619,247) (
8)
6(26)
(
293,238) (
4) (
177,546) (
2)
6(6)
(
85,789) (
1) (
61,296) (
1)
(
302,831)(
4) (
574,563)(
7)
445,800
6
673,713
9
6(29)
(
281,516) (
4) (
228,081) (
3)
$ 164,284
2
$ 445,632
6

4000
Operating income
5000
Operating costs
5900
Gross profit
Operating Expenses
6100
Selling Expenses
6200
Administrative Expenses
6300
R&D Expenses
6450
Expected loss on credit impairment
6000
Total Operating Expenses
6900
Operating profit
Non-operating income and expenses
7100
Interest income
7010
Other Incomes
7020
Other Gains and Losses
7050
Financial Costs
7060
The share of affiliates and joint venture
profits and losses recognized by the
equity method
7000
Total Non-Operating Incomes and
Losses
7900
Earnings Before Tax
7950
Income Tax Expense
8200
Net profit for the period

(continued on next page)

-23-

Taiwan Mask Corporation and Subsidiaries Consolidated Comprehensive Income Statement January 1 to December 31, 2023, and 2022

Unit: NT$Thousand (Except for earnings per share)

Items	2023 2022 Notes Amount % Amount % 6(17) ($ 1,145 ) - ($ 2,656 ) - ( 1,145 ) - ( 2,656 ) - 6(21) ( 8,867 ) - 6,476 - ( 8,867 ) - 6,476 - ($ 10,012 ) - $ 3,820 - $ 154,272 2 $ 449,452 6 $ 366,126 5 $ 703,519 9 ( 201,842 ) ( 3) ( 257,887 ) ( 3) $ 164,284 2 $ 445,632 6 $ 356,114 5 $ 707,339 9 ( 201,842 ) ( 3) ( 257,887 ) ( 3) $ 154,272 2 $ 449,452 6 6(30) $ 1.75 $ 3.37 6(30) $ 1.65 $ 3.12
Other Comprehensive Incomes (Net) Components of other comprehensive income that will not be reclassified to profit or loss 8311 Re-measurements of defined benefit plan 8310 Total items that will not be reclassified subsequently to profit or loss Components of other comprehensive income that will be reclassified to profit or loss 8361 Financial statement translation differences of foreign operations 8360 Total Components of other comprehensive income that will be reclassified to profit or loss 8300 Other Comprehensive Incomes (Net) 8500 Total comprehensive income for the year Net Incomes (Losses) Attributable to: 8610 Parent Company 8620 Non-controlling Interests Total Total Comprehensive Incomes (Losses) Attributable to: 8710 Parent Company 8720 Non-controlling Interests Total Earnings per share 9750 Net Income Diluted Earnings per share 9850 Net profit for the period

Items

2023
2022
Notes
Amount
%
Amount
%
6(17)
($ 1,145 )
- ($ 2,656 )
-
(
1,145 )
- (
2,656 )
-
6(21)
(
8,867 )
-
6,476
-
(
8,867 )
-
6,476
-
($ 10,012 )
-
$ 3,820
-
$ 154,272
2
$ 449,452
6
$ 366,126
5
$ 703,519
9
(
201,842 ) (
3) (
257,887 ) (
3)
$ 164,284
2
$ 445,632
6
$ 356,114
5
$ 707,339
9
(
201,842 ) (
3) (
257,887 ) (
3)
$ 154,272
2
$ 449,452
6
6(30)
$ 1.75
$ 3.37
6(30)
$ 1.65
$ 3.12

Other Comprehensive Incomes (Net)
Components of other comprehensive
income that will not be reclassified to
profit or loss
8311
Re-measurements of defined benefit plan
8310
Total items that will not be reclassified
subsequently to profit or loss
Components of other comprehensive
income that will be reclassified to profit
or loss
8361
Financial statement translation differences
of foreign operations
8360
Total Components of other
comprehensive income that will be
reclassified to profit or loss
8300
Other Comprehensive Incomes (Net)
8500
Total comprehensive income for the year
Net Incomes (Losses) Attributable to:
8610
Parent Company
8620
Non-controlling Interests
Total
Total Comprehensive Incomes (Losses)
Attributable to:
8710
Parent Company
8720
Non-controlling Interests
Total
Earnings per share
9750
Net Income
Diluted Earnings per share
9850
Net profit for the period

The accompanying notes are an integral part of the consolidated financial statements.

Managerial Officer: Lidon Chen

Chairman: Sean Chen

Accounting Supervisor: Eve Yang

-24-

Taiwan Mask Corporation and Subsidiaries ConsolidatedStatement of Changes in Equity January 1 to December 31, 2023, and 2022

Unit: NT$Thousand

Notes			Equity	a	ttributable to share	lders of the parent company	lders of the parent company			Non- controlling Interests
	Capital stock	Capital surplus	Retain	ed	earnings	Other equity interests		Treasury stock	Total
			Legal reserve		Unappropriated earnings	Translation of Foreign Financial Statements Exchange Differences on	Unrealized gains (losses) on financial assets measured at fair value through other comprehensive income
6(21) 6(20) 6 (19)(20) 6(19) 6(19) 6(19) 6 (18)(19) 6(18) 6(18) 6(21) 6(20) 6 (19)(20) 6(19) 6(19) 6(19) 6(18) 6(18) 6(19)	$ 2,556,735 - - - - - 7,730 - - - - - - - - $ 2,564,465 $ 2,564,465 - - - - - - - - - - - - - $ 2,564,465	$ 1,315,828 - - - - - 55,472 ( 241,189 ) 73,463 10,169 21,107 16,831 - - - $ 1,251,681 $ 1,251,681 - - - - - ( 49,797 ) 90,829 133,604 13,793 - - ( 151 ) - $ 1,439,959	$ 656,037 - - - 113,915 - - - - - - - - - - $ 769,952 $ 769,952 - - - 57,508 - - - - - - - - - $ 827,460		$ 1,470,151 703,519 ( 2,656 ) 700,863 ( 113,915 ) ( 241,189 ) - - - ( 86,617 ) - - - - - $ 1,729,293 $ 1,729,293 366,126 ( 1,145 ) 364,981 ( 57,508 ) ( 572,665 ) - - - - - - - - $ 1,464,101	$ 6,698 - 6,476 6,476 - - - - - - - - - - - $ 13,174 $ 13,174 - ( 8,867 ) ( 8,867 ) - - - - - - - - - - $ 4,307	($ 2,666 ) - - - - - - - - - - - - - - ($ 2,666 ) ($ 2,666 ) - - - - - - - - - - - - - ($ 2,666 )	($ 941,423 ) - - - - - - - - - - - ( 842,536 ) 4,980 - ($ 1,778,979 ) ($ 1,778,979 ) - - - - - - - - - 12,807 591,688 - - ($ 1,174,484 )	$ 5,061,360 703,519 3,820 707,339 - ( 241,189 ) 63,202 ( 241,189 ) 73,463 ( 76,448 ) 21,107 16,831 ( 842,536 ) 4,980 - $ 4,546,920 $ 4,546,920 366,126 ( 10,012 ) 356,114 - ( 572,665 ) ( 49,797 ) 90,829 133,604 13,793 12,807 591,688 ( 151 ) - $ 5,123,142	($ 187,509 ) ( 257,887 ) - ( 257,887 ) - - - - - - 130,213 2,230 - - 200,240 ($ 112,713 ) ($ 112,713 ) ( 201,842 ) - ( 201,842 ) - - - - ( 58,871 ) - - - - 299,600 ($ 73,826 )	$ 4,873,851 445,632 3,820 449,452 - ( 241,189 ) 63,202 ( 241,189 ) 73,463 ( 76,448 ) 151,320 19,061 ( 842,536 ) 4,980 200,240 $ 4,434,207 $ 4,434,207 164,284 ( 10,012 ) 154,272 - ( 572,665 ) ( 49,797 ) 90,829 74,733 13,793 12,807 591,688 ( 151 ) 299,600 $ 5,049,316

The accompanying notes are an integral part of the consolidated financial statements.

Managerial Officer: Lidon Chen

Chairman: Sean Chen

Accounting Supervisor: Eve Yang

-25-

Taiwan Mask Corporation and Subsidiaries Consolidated Cash Flow Statements January 1 to December 31, 2023, and 2022

Unit: NT$Thousand

Cash Flow from Operating Activities
Net Income (Loss) Before Tax
Adjustments to Reconcile Net Income to Net Cash Flow
from Operating Activities
Revenues and Expenses
Depreciation

Amortization

Expected loss on credit impairment

Interest income

Interest Expenses

Subsidiaries donated treasury stock

Net losses of financial assets at fair value
through profit or loss

Gain (loss) on disposal of investments

Dividend income

Share-based payment transaction

Share of losses of affiliated companies
recognized under the equity method

Disposal of interests in property, plant and
equipment

Gains on disposal of intangible assets

Property, plant and equipment reclassified as
expenses
The Changes of Assets/ Liabilities related to
Operating Activities
Net Changes of Assets related to Operating
Activities
Mandatory financial assets at fair value through
profit or loss
Contract Assets
Notes Receivables
Accounts Receivables
Accounts Receivables－Related Parties
Other Receivables
Other Receivables－Related Parties
Inventories
Prepayments
Other Current Assets
Other Non-Current Assets
Net Changes of Liabilities related to Operating
Activities
Contract Liabilities
Notes Payable
Accounts Payable
Accounts payable - Related party
Other Payables
Other Payables- related Parties
Provisions
Other Current Liabilities
Defined Benefit Liabilities
Other Current Liabilities
Net Cash In-Flow from Operating
Dividends Received
Interest Received
Interest Paid
Income Tax Paid
Net Cash In-Flow from Operating Activities Notes
January 1, 2023
to December 31,2019
January 1, 2022
to December 31,2019
$ 445,800 $ 673,713
6(27)
933,404
568,193
6(27)
52,495
45,391
12(2)
9,455
10,558
6(23)
(
40,742 ) (
25,271 )
6(26)
293,238
177,546
7
12,807
4,980
6(25)
221,510
801,122
6(25)
(
101,102 ) (
123,552 )
6(24)
(
94,064 ) (
194,598 )
6(18)
-
19,061
6(6)
85,789
61,296
6(25)
(
688 ) (
5,024 )
6(25)
(
25,499 )
-
78
1,186
(
175,131 ) (
115,356 )
34,968
15,532
(
4,604 ) (
1,298 )
28,959 (
247,822 )
2,320
14,466
(
16,753 )
55,246
(
407 )
-
(
250,767 )
21,187
(
40,501 ) (
158,379 )
35,911 (
14,837 )
29,108
671
(
67,726 )
53,463
(
79,735 )
15
27,826 (
60,057 )
(
284 )
284
49,752
144,840
304
-
- (
10,964 )
17,970 (
167 )
(
7,012 )
4,169
(
7,228) (
98,218)
1,369,451
1,617,376
110,914
194,598
42,243
25,271
(
260,590 ) (
177,546 )
(
444,991 ) (
246,930)
817,027
1,412,769

(continued on next page)

-26-

Taiwan Mask Corporation and Subsidiaries Consolidated Cash Flow Statements January 1 to December 31, 2023, and 2022

Unit: NT$Thousand

Cash Flow from Investment Activities
Acquisition of Amortized Cost Financial Assets
Disposal of Amortized Cost Financial Assets
Cash outflows from changes in consolidated
entities

Acquisition of investment property by the Equity
Method
Acquisition of Property, Plants and Equipment

Disposal of Property, Plants and Equipment
Acquisition of Intangible Assets

Gains on disposal of intangible assets
Increase in Refundable Deposit
Net Cash Outflow from Investing
Activities
Cash Flows from Financing Activities
Increase of Short Term Loan

Redemption of Short Term Loan

Increase of Long Term Loan

Redemption of Long Term Loan

Issuance of ordinary corporate bonds

Treasury stocks transfer to employees
Cost of treasury stock buyback
Redemption of Lease Principal

Increase in Guarantee Deposits Received

Distribution of cash dividends (including capital
surplus distribution cash)
Cash increase of non-controlling equity in
Subsidiaries
Payment of overdue unclaimed dividends
Net Cash In-Flow (Out-Flow) from
Funding Activities
Adjustments of Exchange Rate
Increase (Decrease) in Cash and Cash Equivalents
Beginning Balance of Cash and Cash Equivalents
Ending Balance of Cash and Cash Equivalents

Notes
January 1, 2023
to December 31,2019
January 1, 2022
to December 31,2019
( $ 672,781 ) ( $ 610,686 )
416,418
20,882
6(31)
(
78,027 )
-
(
15,000 )
-
6 (32)
(
3,179,581 ) (
2,911,204 )
8,695
6,020
6(11)
(
36,975 ) (
45,767 )
27,043
-
(
35,869 ) (
36,932 )
(
3,566,077 ) (
3,577,687 )
6 (33)
7,613,689
16,200,182
6 (33)
(
6,907,998 ) (
15,952,423 )
6 (33)
1,593,546
4,569,424
6 (33)
(
1,061,577 ) (
3,512,177 )
6 (33)
797,338
997,095
591,688
-
- (
842,536 )
6 (33)
(
51,816 ) (
55,556 )
6 (33)
7,528
27,846
(
531,633 ) (
408,915 )
299,600
200,240
(
151 )
-
2,350,214
1,223,180
12,985
9,876
(
385,851 ) (
931,862 )
1,749,957
2,681,819
6(1)
$ 1,364,106$ 1,749,957

The accompanying notes are an integral part of the consolidated financial statements.

Chairman: Sean Chen

Managerial Officer: Lidon Chen Accounting Supervisor: Eve Yang

27 -

‧

[Attachment 5]

Independent Auditors’ Report

(113) Tsai-Sheng-Bao-Zi No. 23002831

To Taiwan Mask Corporation,

Opinions

We have audited the accompanying parent-only balance sheets of Taiwan Mask Corporation as of December 31, 2023 and 2022, and the related statements of comprehensive income, of changes in equity and of cash flows for the years ended December 31, 2023 and 2022, and notes to the parent-only financial statements, including a summary of significant accounting policies.

In our opinion, based on our audits and the reports of the other independent auditors, as described in the Other matters section of our report, the parent-only financial statements present fairly, in all material respects, the standalone financial position of Taiwan Mask Corporation as of December 31, 2023 and 2022, and its financial performance and its cash flows for the years ended December 31, 2023 and 2022, in accordance with the “Regulations Governing the Preparation of Financial Reports by Securities Issuers”.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards generally accepted in Taiwan. Our responsibilities under those standards are further described in the Independent Auditor’s Responsibilities for the Audit of the Parent Only Financial Statements section of our report. We are independent of Taiwan Mask Corporation in accordance with the Code of Professional Ethics for Certified Public Accountants in the Republic of China (the “Code”), and we have fulfilled our other ethical responsibilities in accordance with the Code. Based on our audits and the reports of the other independent auditors, we believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of Taiwan Mask Corporation of fiscal year 2023. These matters were addressed in the context of our audit of the parent only financial statements as a whole and, in forming our opinion thereon, we do not provide a parent only opinion on these matters.

Key audit matters for the parent-only financial statements in fiscal year 2023 are stated as follows:

28 -

Evaluation of Inventories

Explanation

Refer to Note 4(12) for the accounting policies on the valuation of inventories, Note 5(2) for the uncertainty of accounting estimations and assumptions for valuation of inventories, inventory accounts description please refer to Note 6(5), for the details of allowance for inventory valuation. The inventory amount and allowance for inventory valuation loss as of December 31, 2023 is NT$134,369 thousand and NT$4,794 thousand, respectively.

Taiwan Mask Corporation is primarily engaged in mask and integrated circuit services in the semiconductor industry. Due to rapid technological innovations, short life-cycle and competition within the mask industry, the risk of price fluctuations, loss on decline in value of inventories and obsolescence is higher than that of other industries. Management evaluates inventories stated at the lower of cost and net realizable value. Since the evaluation of inventories is subject to management’s judgment and the accounting estimations will have significant influence on the inventory values, the evaluation of inventories has been identified as one of the key audit matters.

How our audit addressed the matter

We have performed primary audit procedures for the above matter as follows:

Understand and evaluate the accounting policy for the provision of allowance for losses on decline in value of inventories.
Perform test to evaluate the ageing statement of inventories and the statement of lower of cost and net realizable value of inventories, including validating the supporting documents related to the date of inventory movement to confirm the correct ageing classification, and validating the supporting documents related to the net realizable value to assess and confirm the reasonableness of the net realizable value determination.
Verify the reasonableness of allowance for inventory valuation loss.

Income recognition

Explanation

For the accounting policy on income recognition, please refer to Note 4(27) of the financial report. For sales revenue please refer to Note 6(21); the operating income in fiscal year 2023 is NT$3,985,541 thousand.

Taiwan Mask Corporation mainly produces and sells products such as masks and integrated circuits used in semiconductors, and has a large and diversified sales base. Trading conditions vary according to market conditions and customer needs. Considering that sales revenue is a major transaction that significantly impacts the standalone financial statements, we believe that the recognition of sales revenue is one of the most important matters to be considered in this year’s audit.

29 -

How our audit addressed the matter

We have performed primary audit procedures for the above matter as follows:

Understand the type of major income and assess internal operations, review revenue recognition and accounting treatment.
Obtain the sales revenue statement, sample the sales transactions and verify the relevant documents to determine the appropriateness of the sales revenue.
Execute the cut-off test for the sales receipts transaction for a certain period of time before and after the closing date, and confirm that the account is correct at the time of entry.

Responsibilities of management and those charged with governance for the parent only financial statements

Management is responsible for the preparation and fair presentation of the parent only financial statements in accordance with the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations as endorsed by the Financial Supervisory Commission, and for such internal control as management determines is necessary to enable the preparation of parent only financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the parent only financial statements, management is responsible for assessing Taiwan Mask Corporation’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate Taiwan Mask Corporation or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the Audit Committee, are responsible for overseeing Taiwan Mask Corporation’s financial reporting process.

Independent auditor’s responsibilities for the audit of the parent only financial statements

Our objectives are to obtain reasonable assurance about whether the parent only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors’ Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ROC AS will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, Individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these parent only financial statements.

As part of an audit conducted in accordance with ROC AS, we exercise professional judgment and professional skepticism throughout the audit. We also conduct the following undertakings:

30 -
Identify and assess the risks of material misstatement of the parent only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Taiwan Mask Corporation’s internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on Taiwan Mask Corporation’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our report to the related disclosures in the parent only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our report. However, future events or conditions may cause Taiwan Mask Corporation to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the parent only financial statements, including the disclosures, and whether the parent only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within Taiwan Mask Corporation to express an opinion on the parent only financial statements. We are responsible for the direction, supervision and performance of the audit. We remain solely responsible for our audit opinion.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the parent-only financial statements for the year ended

31 -

December 31, 2023, and are therefore the key audit matters. We describe these matters in our Auditors’ Report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our auditor’s report because the adverse consequences of doing so would reasonable are expected to outweigh the public interest benefits of such communication.

PricewaterhouseCoopers Taiwan

Ya-Hui Cheng

Accountant

Chien-Yu Liu

Securities and Futures Bureau of Financial Supervisory Commission of the Executive Yuan

Approval Certificate No. 0960072936

Financial Supervisory Commission of the Executive Yuan

Approval Document for Attestation: Jin-Guan-Zheng-Shen-Zi No. 1090350620

March 6, 2024

32 -

Taiwan Mask Corporation Parent Company Only Comprehensive Income Statement December 31, 2023 and 2022

Assets	Notes 6(1) 6(2) and 8 6(3) 6(21) 6(4) 6(4) and 7 7 6(5) 6(2) and 8 6(3) and 8 6(6) 6(7) and 8 6(8) 6(10) and 8 6(28) 6(11)	December31,2023 Amount % $ 451,993 3 397,340 3 3,000 - 86,821 - 685,798 5 6,494 - 4,520 - 90,940 - 129,575 1 97,617 1 190 - 1,954,288 13 859,962 6 417,504 3 1,866,791 13 7,862,213 54 535,527 4 662,854 5 45,675 - 5,310 - 359,147 2 12,614,983 87 $ 14,569,271 100	Unit: NT$Thousand December31,2022 Amount % $ 1,211,411 9 307,448 2 3,000 - 90,642 1 800,431 6 9,525 - 4,566 - 17,443 - 118,709 1 104,427 1 803 - 2,668,405 20 925,006 7 222,774 2 1,897,832 15 4,762,328 37 541,438 4 683,746 5 41,720 - 1,780 - 1,331,600 10 10,408,224 80 $ 13,076,629 100
		Amount $ 451,993 397,340 3,000 86,821 685,798 6,494 4,520 90,940 129,575 97,617 190 1,954,288 859,962 417,504 1,866,791 7,862,213 535,527 662,854 45,675 5,310 359,147 12,614,983 $ 14,569,271	Amount $ 1,211,411 307,448 3,000 90,642 800,431 9,525 4,566 17,443 118,709 104,427 803 2,668,405 925,006 222,774 1,897,832 4,762,328 541,438 683,746 41,720 1,780 1,331,600 10,408,224 $ 13,076,629
Current assets 1100 Cash and Cash Equivalents 1110 Financial Assets at Fair Value Through Profit or Loss - Current 1136 Financial Assets at Amortized Cost - Current 1140 Contract Asset - Current 1170 Accounts Receivables (Net) 1180 Accounts Receivables - Related Parties (Net) 1200 Other Receivables 1210 Other Receivables - Related Parties 130X Inventories 1410 Prepayments 1470 Other Current Assets 11XX Total Current Assets Non-Current Assets 1510 Financial Assets at Fair Value Through Profit or Loss - Non Current 1535 Financial Assets at Amortized Cost - Non Current 1550 Investment under Equity Method 1600 Property, plant and equipment 1755 Right-of-use Asset 1760 Investment property (Net) 1780 Intangible assets 1840 Deferred Income Tax Assets 1900 Other Non-Current Assets 15XX Total Non-Current Assets 1XXX Total Assets

(continued on next page)

-33-

Taiwan Mask Corporation Parent Company Only Comprehensive Income Statement December 31, 2023 and 2022

Liabilities and Equities	Unit: NT$Thousand December31,2023 December31,2022 Notes Amount % Amount % 6(12) $ 1,079,983 8 $ 1,054,934 8 6(2) 9,383 - 5,697 - 6(21) 33,984 - 57,323 1 117,596 1 109,004 1 6(13) 669,580 5 520,173 4 7 4,131 - - - 2,623 - 150,791 1 31,939 - 30,682 - 6(15) 872,834 6 484,737 4 47,783 - 29,182 - 2,869,836 20 2,442,523 19 6(14) 3,424,600 23 2,609,044 20 6(15) 2,592,429 18 2,905,263 22 6(28) 219 - 3,850 - 514,436 4 518,641 4 6(16) 10,648 - 16,514 - 6(31) 33,961 - 33,874 - 6,576,293 45 6,087,186 46 9,446,129 65 8,529,709 65 6(17) 2,564,465 18 2,564,465 20 6(18) 1,439,959 9 1,251,681 10 6(19) 827,460 6 769,952 6 1,464,101 10 1,729,293 13 6(20) 1,641 - 10,508 - 6(17) ( 1,174,484 ) ( 8 ) ( 1,778,979) ( 14) 5,123,142 35 4,546,920 35 9 11 $ 14,569,271 100 $ 13,076,629 100
Current liabilities 2100 Short Term Loans 2120 Financial liabilities at fair value through profit or loss - Current 2130 Contract Liabilities - Current 2170 Accounts Payable 2200 Other Payables 2220 Other Payables - Related Parties 2230 Income Tax Liabilities for the Period 2280 Lease Liability - Current 2320 Long-term liabilities due within one year or one business cycle 2399 Other Current Liabilities - Other 21XX Total Current Liabilities Non-current liabilities 2530 Corporate bonds payable 2540 Long-term Loans 2570 Deferred Income Tax 2580 Lease liability - Non Current 2640 Defined Benefit Liabilities - Non Current 2645 Guarantee Deposits Received 25XX Total Non-Current Liabilities 2XXX Total Liabilities Capital 3110 Capital stock Capital surplus 3200 Capital surplus Retained earnings 3310 Legal reserve 3350 Unappropriated earnings Other equity interests 3400 Other equity interests 3500 Treasury stock 3XXX Total Equities Major Commitments and Contingencies Major Events after Financial Statement Date 3X2X Total Liabilities and Equities

Liabilities and Equities

Unit: NT$Thousand
December31,2023

December31,2022
Notes
Amount
%
Amount

%
6(12)
$ 1,079,983
8
$ 1,054,934
8
6(2)
9,383
-
5,697
-
6(21)
33,984
-
57,323
1
117,596
1
109,004
1
6(13)
669,580
5
520,173
4
7
4,131
-
-
-
2,623
-
150,791
1
31,939
-
30,682
-
6(15)
872,834
6
484,737
4
47,783
-
29,182
-
2,869,836
20
2,442,523
19
6(14)
3,424,600
23
2,609,044
20
6(15)
2,592,429
18
2,905,263
22
6(28)
219
-
3,850
-
514,436
4
518,641
4
6(16)
10,648
-
16,514
-
6(31)
33,961
-
33,874
-
6,576,293
45
6,087,186
46
9,446,129
65
8,529,709
65
6(17)
2,564,465
18
2,564,465
20
6(18)
1,439,959
9
1,251,681
10
6(19)
827,460
6
769,952
6
1,464,101
10
1,729,293
13
6(20)
1,641
-
10,508
-
6(17)
(
1,174,484 ) (
8 ) (
1,778,979) (
14)
5,123,142
35
4,546,920
35
9
11
$ 14,569,271
100
$ 13,076,629
100

Current liabilities
2100
Short Term Loans
2120
Financial liabilities at fair value
through profit or loss - Current
2130
Contract Liabilities - Current
2170
Accounts Payable
2200
Other Payables
2220
Other Payables - Related Parties
2230
Income Tax Liabilities for the Period
2280
Lease Liability - Current
2320
Long-term liabilities due within one
year or one business cycle
2399
Other Current Liabilities - Other
21XX
Total Current Liabilities
Non-current liabilities
2530
Corporate bonds payable
2540
Long-term Loans
2570
Deferred Income Tax
2580
Lease liability - Non Current
2640
Defined Benefit Liabilities - Non
Current
2645
Guarantee Deposits Received
25XX
Total Non-Current Liabilities
2XXX
Total Liabilities
Capital
3110
Capital stock
Capital surplus
3200
Capital surplus
Retained earnings
3310
Legal reserve
3350
Unappropriated earnings
Other equity interests
3400
Other equity interests
3500
Treasury stock
3XXX
Total Equities
Major Commitments and Contingencies
Major Events after Financial Statement
Date
3X2X
Total Liabilities and Equities

The attached notes to the standalone financial statements are part of the standalone financial report.

Chairman: Sean Chen

Managerial Officer: Lidon Chen

Accounting Supervisor: Eve Yang

-34-

Taiwan Mask Corporation Parent Only Income Statement

January 1 to December 31, 2023, and 2022

Unit: NT$Thousand (Except for earnings per share)

Items	2023 2022 Notes Amount % Amount % 6 (21) and 7 $ 3,985,541 100 $ 3,887,648 100 6(5) ( 2,322,564) ( 58) ( 1,796,579 )( 46) 1,662,977 42 2,091,069 54 6(26) (27) ( 75,496 ) ( 2) ( 63,495 ) ( 2) ( 304,800 ) ( 8) ( 272,202 ) ( 7) ( 152,015 ) ( 4) ( 92,972 ) ( 2) 12(2) ( 418) - ( 821 ) - ( 532,729) ( 14) ( 429,490 )( 11) 1,130,248 28 1,661,579 43 6(22) 27,316 1 11,798 - 6(23) 204,573 5 195,387 5 6(24) ( 8,162 ) - ( 205,013 ) ( 5) 6(25) ( 162,406 ) ( 4) ( 91,694 ) ( 2) ( 579,274) ( 15) ( 676,888 )( 18) ( 517,953) ( 13) ( 766,410 )( 20) 612,295 15 895,169 23 6(28) ( 246,169 ) ( 6) ( 191,650 )( 5) $ 366,126 9 $ 703,519 18 6(16) ($ 1,145 ) - ( $ 2,721 ) - - - 65 - ( 1,145) - ( 2,656 ) - 6(20) ( 8,867) - 6,476 - ( 8,867) - 6,476 - ($ 10,012) - $ 3,820 - $ 356,114 9 $ 707,339 18 6(29) $ 1.75 $ 3.37 6(29) $ 1.65 $ 3.12
4000 Operating income 5000 Operating costs 5900 Gross profit Operating expenses 6100 Selling Expenses 6200 Administrative Expenses 6300 R&D Expenses 6450 Expected loss on credit impairment 6000 Total Operating Expenses 6900 Operating profit Non-operating income and expenses 7100 Interest income 7010 Other Incomes 7020 Other Gains and Losses 7050 Financial Costs 7070 The share of subsidiaries, affiliates and joint venture profits and losses recognized by the equity method 7000 Total Non-Operating Incomes and Losses 7900 Earnings Before Tax 7950 Income Tax Expense 8200 Net profit for the period Other Comprehensive Incomes (Net) Components of other comprehensive income that will not be reclassified to profit or loss 8311 Re-measurements of defined benefit plan 8330 Profit and loss of subsidiaries, associates and joint ventures recognized by using equity method - Items that will not be reclassified to profit or loss 8310 Total items that will not be reclassified subsequently to profit or loss Components of other comprehensive income that will be reclassified to profit or loss 8361 Financial statement translation differences of foreign operations 8360 Total Components of other comprehensive income that will be reclassified to profit or loss 8300 Other Comprehensive Incomes (Net) 8500 Total comprehensive income for the year Earnings per share 9750 Net Income (Loss) Diluted Earnings per share 9850 Net profit for the period

Items

2023
2022
Notes
Amount
%
Amount
%
6 (21) and 7 $ 3,985,541
100
$ 3,887,648
100
6(5)
(
2,322,564) (
58) (
1,796,579 )(
46)
1,662,977
42
2,091,069
54
6(26)
(27)
(
75,496 ) (
2) (
63,495 ) (
2)
(
304,800 ) (
8) (
272,202 ) (
7)
(
152,015 ) (
4) (
92,972 ) (
2)
12(2)
(
418)
-
(
821 )
-
(
532,729) (
14) (
429,490 )(
11)
1,130,248
28
1,661,579
43
6(22)
27,316
1
11,798
-
6(23)
204,573
5
195,387
5
6(24)
(
8,162 )
-
(
205,013 ) (
5)
6(25)
(
162,406 ) (
4) (
91,694 ) (
2)
(
579,274) (
15) (
676,888 )(
18)
(
517,953) (
13) (
766,410 )(
20)
612,295
15
895,169
23
6(28)
(
246,169 ) (
6) (
191,650 )(
5)
$ 366,126
9
$ 703,519
18
6(16)
($ 1,145 )
-
( $ 2,721 )
-
-
-
65
-
(
1,145)
-
(
2,656 )
-
6(20)
(
8,867)
-
6,476
-
(
8,867)
-
6,476
-
($ 10,012)
-
$ 3,820
-
$ 356,114
9
$ 707,339
18
6(29)
$ 1.75
$ 3.37
6(29)
$ 1.65
$ 3.12

4000
Operating income
5000
Operating costs
5900
Gross profit
Operating expenses
6100
Selling Expenses
6200
Administrative Expenses
6300
R&D Expenses
6450
Expected loss on credit impairment
6000
Total Operating Expenses
6900
Operating profit
Non-operating income and expenses
7100
Interest income
7010
Other Incomes
7020
Other Gains and Losses
7050
Financial Costs
7070
The share of subsidiaries, affiliates and joint
venture profits and losses recognized by the
equity method
7000
Total Non-Operating Incomes and Losses
7900
Earnings Before Tax
7950
Income Tax Expense
8200
Net profit for the period
Other Comprehensive Incomes (Net)
Components of other comprehensive income
that will not be reclassified to profit or loss
8311
Re-measurements of defined benefit plan
8330
Profit and loss of subsidiaries, associates and
joint ventures recognized by using equity
method - Items that will not be reclassified to
profit or loss
8310
Total items that will not be reclassified
subsequently to profit or loss
Components of other comprehensive income
that will be reclassified to profit or loss
8361
Financial statement translation differences of
foreign operations
8360
Total Components of other comprehensive
income that will be reclassified to profit or
loss
8300
Other Comprehensive Incomes (Net)
8500
Total comprehensive income for the year
Earnings per share
9750
Net Income (Loss)
Diluted Earnings per share
9850
Net profit for the period

The attached notes to the standalone financial statements are part of the standalone financial report.

Chairman: Sean Chen

Managerial Officer: Lidon Chen Accounting Supervisor: Eve Yang

-35-

Taiwan Mask Corporation Parent Company Only Statement of Changes in Equity January 1 to December 31, 2023, and 2022

Unit: NT$Thousand

	Capital surplus			Retained earnings	Retained earnings		Other equityinterests	Other equityinterests	Other equityinterests
			Legal reserve	Special reserve $ - - - - - - - - - - - - - - $ - $ - - - - - - - - - - - - - $ -	Unappropriated earnings		Translation o Foreign Financ Statements Exchange Differences o	f ial n	Unrealized gains (losses) on financial assets measured at fair value through other available-for-sale financial assets
$	1,315,828 - - - - - 55,472 241,189 ) 73,463 10,169 21,107 16,831 - - 1,251,681 1,251,681 - - - - - 49,797 ) 90,829 133,604 13,793 - - 151 ) 1,439,959	$	656,037 - - - 113,915 - - - - - - - - - 769,952 769,952 - - - 57,508 - - - - - - - - 827,460		$ 1,470,151 703,519 ( 2,656 ) 700,863 ( 113,915 ) ( 241,189 ) - - - ( 86,617 ) - - - - $ 1,729,293 $ 1,729,293 366,126 ( 1,145 ) 364,981 ( 57,508 ) ( 572,665 ) - - - - - - - $ 1,464,101	$	6,698 - 6,476 6,476 - - - - - - - - - - 13,174 13,174 - 8,867 ) 8,867 ) - - - - - - - - - 4,307	($


(
$		$				$		($
$		$				$		($
						(
						(
( (
$		$				$		($

Chairman: Sean Chen

The attached notes to the parent only financial statements are part of the parent only financial report and should be read in conjunction. Managerial Officer: Lidon Chen

Accounting Supervisor: Eve Yang

-36-

Taiwan Mask Corporation Parent Company Only Cash Flow Statements January 1 to December 31, 2023, and 2022

Unit: NT$Thousand

Cash Flow from Operating Activities
Net Income(Loss) Before Tax
Adjustments to Reconcile Net Income to Net Cash Flow
from Operating Activities
Revenues and Expenses
Depreciation

Amortization

Expected loss on credit impairment

Dividend income

Interest income

Interest Incomes

Loss (gain) on financial assets measured at fair
value through profit or loss

Loss on disposal of investments

Share-based payment transaction

The Share of Subsidiaries and Affiliates Profits
and Losses Recognized by the Equity Method
Property, plant and equipment reclassified as
expenses

The Changes of Assets/ Liabilities related to
Operating Activities
Net Changes of Assets related to Operating
Activities
Mandatory financial assets at fair value through
profit or loss
Contract Assets
Accounts Receivables
Accounts Receivables－Related Parties
Other Receivables
Other Receivables－Related Parties
Inventories
Prepayments
Other Current Assets
Net Changes of Liabilities related to Operating
Activities
Contract Liabilities
Accounts Payable
Other Payables
Other Payables- related Parties
Other Current Liabilities
Defined Benefit Liabilities
Net Cash In-Flow from Operating
Dividends Received
Interest Received
Interest Paid
Income Tax Paid
Net Cash In-Flow (Out-Flow) from Operating
Activities Notes
January 1, 2023
to December 31,
2019
January 1, 2022
to December 31,
2019
$ 612,295 $ 895,169
6(26)
798,565
513,116
6(26)
24,041
6,284
12(2)
418
821
6(23)
(
51,566 ) (
33,682 )
6(22)
(
27,317 ) (
11,798 )
6(25)
162,406
91,694
6(24)
(
8,662 )
114,183
6(24)
-
119,316
6(17)
-
14,131
579,274
676,888
6(7)
78
116
(
12,500 ) (
357,348 )
3,821
25,212
114,215 (
208,285 )
3,031 (
4,413 )
(
1,455 )
993
(
73,497 ) (
2,573 )
(
10,866 ) (
8,820 )
7,020 (
67,468 )
613
170
(
23,339 )
49,663
8,592
27,553
7,370
29,844
1,626
-
18,601 (
3,385 )
(
7,012 ) (
1,749 )
2,125,752
1,865,632
69,929
70,496
28,813
10,065
(
134,928 ) (
90,670 )
(
401,498 ) (
157,909)
1,688,068
1,697,614

(continued on next page)

-37-

Taiwan Mask Corporation Parent Company Only Cash Flow Statements January 1 to December 31, 2023, and 2022

Cash Flow from Investment Activities
Acquisition of Amortized Cost Financial Assets
Disposal of Amortized Cost Financial Assets
Acquisition of investment property by the Equity
Method
Acquisition of Property, Plants and Equipment

Acquisition of Intangible Assets
Increase in refundable deposit
Net Cash Outflow from Investing
Activities
Cash Flows from Financing Activities
Increase of Short Term Loan

Redemption of Short Term Loan

Increase of Long Term Loan

Redemption of Long Term Loan

Issuance of ordinary corporate bonds

Distribution of cash dividends (including capital
surplus distribution cash)

Treasury stocks transfer to employees

Cost of treasury stock buyback

Redemption of Lease Principal

Increase in Guarantee Deposits Received

Transfer of unclaimed dividends as Additional
Paid-in Capital
Net Cash In-Flow (Out-Flow) from
Funding Activities
Increase (Decrease) in Cash and Cash Equivalents
Beginning Balance of Cash and Cash Equivalents
Ending Balance of Cash and Cash Equivalents

Unit: NT$Thousand
Notes
January 1, 2023
to December 31,
2019
January 1, 2022
to December 31,
2019
( $ 527,651 ) ( $ 187,349 )
332,921
-
(
324,431 )
-
6(30)
(
2,732,591 ) (
2,662,286 )
(
27,996 ) (
39,486 )
(
1,431 ) (
2,370 )
(
3,281,179 ) (
2,891,491 )
6(31)
4,395,672
5,662,100
6(31)
(
4,370,623 ) (
5,467,166 )
6(31)
930,631
4,624,737
6(31)
(
855,368 ) (
3,884,737 )
6(31)
797,338
997,095
6(19)
(
622,462 ) (
482,378 )
6(17)
591,688
-
6(17)
- (
842,536 )
6(31)
(
33,119 ) (
29,737 )
6(31)
87
29,069
(
151 )
-
833,693
606,447
(
759,418 ) (
587,430 )
1,211,411
1,798,841
$ 451,993 $ 1,211,411

The attached notes to the standalone financial statements are part of the standalone financial report.

Managerial Officer: Lidon Chen

Chairman: Sean Chen

Accounting Supervisor: Eve Yang

-38-

[Attachment 6]

Taiwan Mask Corporation 2023 Annual Profit Distribution Table

Unit: NTD

Items	Amount
Undistributed earnings at the beginning of the period Add: Effect of changes in shares outstanding due to transfer of treasury stocks to employees Adjusted undistributed earnings at the beginning of the period The remeasurement of the defined benefit plan recognized in retained earnings. Changes in shares of affiliates and joint ventures recognized under the equity method Adjusted undistributed earnings Net Income (Loss) Less: Legal reserve Less: Cash dividends (NT$1.5 per share) Undistributed earnings at the end of the period	1,115,273,379 (16,152,900)
	1,099,120,479
	(1,145,002) 0
	1,097,975,477
	366,125,802 (36,498,080) (373,476,713)
	1,054,126,486

Note:

Pursuant to Article 23-1 of the Company’s Articles of Incorporation, the Company may authorize the board to distribute stock dividends and cash dividends wholly or partially in cash.
The distribution of cash dividends this time adopts the calculation method of “round down to the nearest dollar,” fractions that do not amount to a full NT$1 shall be added and recognized by the Company as other income.
While the distribution of earnings is kept at NT$1.5 per share, if there are regulatory changes by the competent authority or changes to the Company's capital prior to the record date, such as conversion of convertible bonds into equity, which affect the number of shares outstanding before the dividends record date, the chairman is authorized to make changes to the profit distribution schedule, dividends record date and payment date and other relevant matters.

Chairman: Manager: Accounting Officer:

==> picture [25 x 8] intentionally omitted <==

----- Start of picture text -----

- 39 -
----- End of picture text -----

[Attachment 7]

Taiwan Mask Corporation

Comparison of Amendments to the Articles of Incorporation

Amended Articles	Current Articles	Explanation
Article 2 The business of the Company shall be as follows: CC01080 Electronic Parts and Components Manufacturing CA01050 Steel Secondary Processing CA02010 Aluminum Rolling, Drawing, and Extruding CB01010 Mechanical Equipment Manufacturing F401010 International Trade Research, design, development, manufacturing and sales of the following products or services: I. Research and development, production, manufacturing and sales of photomask. II. Welding of steel structures III. Building structure engineering, offshore wind power engineering, pressure vessels, and processing and manufacturing of thick metal plates IV. Laser welding equipment V. To provide technical assistance, consulting, testing and certification, maintenance and repair services relating to the aforesaid products.	Article 2 The business of the Company shall be as follows: CC01080 Electronic Parts and Components Manufacturing F401010 International Trade I. Research and development, production, manufacturing and sales of photomask. II. To provide technical assistance, consulting, testing and certification, maintenance and repair services relating to the aforesaid products.	Revised in line with future operations and development.
I. II.
III.
IV.
V.
Article 26 The Articles of Incorporation were established on October 7,1988. The 1st	Article 26 The Articles of Incorporation were established on October 7,1988. The 1st	Added the date of amendment

40 -

	Amended Articles	Current Articles	Explanation
	amendment was made on May 29, 1990. The 2nd amendment was made on April 2, 1991, and the 3rd amendment was made on May 4, 1992. The 4th amendment was made on April 26, 1994. The 5th amendment was made on May 28, 1994. The 6th amendment was made on June 6, 1995. The 7th amendment was made on June 1, 1996. The 8th amendment was made on May 21, 1997. The 9th amendment was made on May 21, 1998. The 10th amendment was made on May 5, 1999. The 11th amendment was made on June 12, 2000. The 12th amendment was made on April 24, 2001. The 13th amendment was made on May 28, 2002. The 14th amendment was made on June 3, 2003. The 15th amendment was made on June 24, 2004. The 16th amendment was made on June 12, 2006. The 17th amendment was made on June 18, 2010. The 18th amendment was made on June 22, 2011. The 19th amendment was made on June 23, 2016. The 20th amendment was made on June 23, 2017. The 21st amendment was made on June 11, 2019. The 22nd amendment was made on June 10, 2020. The 23rd amendment was made on May 26, 2022. The 24th amendment was made on May 24, 2023.The 25th amendment was made on May 27, 2024.	amendment was made on May 29, 1990. The 2nd amendment was made on April 2, 1991, and the 3rd amendment was made on May 4, 1992. The 4th amendment was made on April 26, 1994. The 5th amendment was made on May 28, 1994. The 6th amendment was made on June 6, 1995. The 7th amendment was made on June 1, 1996. The 8th amendment was made on May 21, 1997. The 9th amendment was made on May 21, 1998. The 10th amendment was made on May 5, 1999. The 11th amendment was made on June 12, 2000. The 12th amendment was made on April 24, 2001. The 13th amendment was made on May 28, 2002. The 14th amendment was made on June 3, 2003. The 15th amendment was made on June 24, 2004. The 16th amendment was made on June 12, 2006. The 17th amendment was made on June 18, 2010. The 18th amendment was made on June 22, 2011. The 19th amendment was made on June 23, 2016. The 20th amendment was made on June 23, 2017. The 21st amendment was made on June 11, 2019. The 22nd amendment was made on June 10, 2020. The 23rd amendment was made on May 26, 2022. The 24th amendment was made on May 24, 2023.

41 -

AI assistant

TMC — AGM Information 2024

52014_rns_2024-06-12_a2b2f256-63c9-465c-b8a8-803b786d75d3.pdf

Taiwan Mask Corporation

Minutes for 2024 Annual General Meeting of Shareholders

IV. Adoption:

V. Discussion topics

No. 1: (Proposed by the Board of Directors)

No. 2: (Proposed by the Board of Directors)

VI. Extempore motions

[Attachment 1]

Taiwan Mask Corporation 2023 Business Report

[Attachment 2]

Taiwan Mask Corporation

Audit Committee’s Audit Report

[Attachment 3]

Endorsement and guarantee of the Company and its subsidiaries for 2023

[Attachment 4]

Independent Auditors ’ Report

Opinions

Basis for Opinion

Key Audit Matters

Evaluation of Inventories

Explanation

How our audit addressed the matter

Income recognition

Explanation

How our audit addressed the matter

Other matters–Parent company only financial reports

Responsibilities of management and those charged with governance for the consolidated financial statements

Independent Auditor’s responsibilities for the audit of the consolidated financial statements

Taiwan Mask Corporation and Subsidiaries Consolidated Balance Sheet December 31, 2023 and 2022

Taiwan Mask Corporation and Subsidiaries Consolidated Balance Sheet December 31, 2023 and 2022

Taiwan Mask Corporation and Subsidiaries Consolidated Comprehensive Income Statement January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation and Subsidiaries Consolidated Comprehensive Income Statement January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation and Subsidiaries ConsolidatedStatement of Changes in Equity January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation and Subsidiaries Consolidated Cash Flow Statements January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation and Subsidiaries Consolidated Cash Flow Statements January 1 to December 31, 2023, and 2022

[Attachment 5]

Independent Auditors’ Report

Opinions

Basis for Opinion

Key Audit Matters

Evaluation of Inventories

Explanation

How our audit addressed the matter

Income recognition

Explanation

How our audit addressed the matter

Responsibilities of management and those charged with governance for the parent only financial statements

Independent auditor’s responsibilities for the audit of the parent only financial statements

Taiwan Mask Corporation Parent Company Only Comprehensive Income Statement December 31, 2023 and 2022

Taiwan Mask Corporation Parent Company Only Comprehensive Income Statement December 31, 2023 and 2022

Taiwan Mask Corporation Parent Only Income Statement

January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation Parent Company Only Statement of Changes in Equity January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation Parent Company Only Cash Flow Statements January 1 to December 31, 2023, and 2022

Taiwan Mask Corporation Parent Company Only Cash Flow Statements January 1 to December 31, 2023, and 2022

[Attachment 6]

Taiwan Mask Corporation 2023 Annual Profit Distribution Table

[Attachment 7]

Taiwan Mask Corporation

More from TMC

TMC AGM Information 2024